FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
The liver plays a crucial role in mobilizing energy during nutritional deprivation. During the early stages of fasting, hepatic glycogenolysis is a primary energy source. As fasting progresses and glycogen stores are depleted, hepatic gluconeogenesis and ketogenesis become major energy sources. Here, we show that fibroblast growth factor 21 (FGF21), a hormone that is induced in liver by fasting, induces hepatic expression of peroxisome proliferator-activated receptor γ coactivator protein-1α (PGC-1α), a key transcriptional regulator of energy homeostasis, and causes corresponding increases in fatty acid oxidation, tricarboxylic acid cycle flux, and gluconeogenesis without increasing glycogenolysis. Mice lacking FGF21 fail to fully induce PGC-1α expression in response to a prolonged fast and have impaired gluconeogenesis and ketogenesis. These results reveal an unexpected relationship between FGF21 and PGC-1α and demonstrate an important role for FGF21 in coordinately regulating carbohydrate and fatty acid metabolism during the progression from fasting to starvation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fibroblast growth factor-21 is a widely expressed protein with a broad mode of action, including the regulation of carbohydrate and fatty acid metabolism283 and may be considered as a myokine due to its secretion from muscle cells.284”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [283]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pharmacological administration of FGF21 or FGF21 analogues exerts lipid-lowering effects through accelerated lipoprotein catabolism108, suppression of postprandial lipolysis in adipose tissues88, decreased hepatic endoplasmic reticulum and oxidative stress109,110, and increased beta-oxidation of lipids in the liver62”
From Metabolic messengers: FGF21 (2021) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is worth noting that FGF21 knockout mice exhibit lower glycemia in the fasted state, and lower plasma levels of ketone bodies in both the fasted and the fed state 64, 65.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [65]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“DKO mice normalized hepatic PGC-1a expression consistent with the regulatory role of Fgf21 (Potthoff et al, 2009;Fig 2H).”
From Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency (2018) · cites this paper as Potthoff et al, 2009
The cited source says what the claim attributes to it.
In the citing paper
“Starvation is one of the stress conditions known to induce FGF21 expression in the liver,8, 32 WAT,10 and skeletal muscle (Figure 2A).6”
From Fibroblast growth factor 21 controls mitophagy and muscle mass (2019) · cites this paper as [32]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125 · cited 3×
“Pharmacologic administration of FGF21 to insulin-resistant rodents and monkeys improves glucose tolerance and reduces plasma insulin and triglyceride concentrations (15, 17).”
BackgroundPuigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865 · cited 1×
“Third, FGF21 causes growth hormone resistance and blunts growth in mice, a phenomenon that occurs during starvation (34).”
BackgroundSelf-citationControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821 · cited 1×
“Because glucagon and its downstream effector, cAMP, induce PGC-1 and gluconeogenic gene expression during the early stages of the fasting response (24, 35), we propose that FGF21 maintains the expression of these genes during prolonged fasting and starvation.”
BackgroundInagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Self-citationBadman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
Finck, B. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27794 · Cited by 1,432
Self-citationDefects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice
Lin, J., Wu, P.-H., Tarr, P. T., Lindenberg, K. S., St-Pierre, J., Zhang, C.-Y., Mootha, V. K., Jäger, S., Vianna, C. R., Reznick, R. M., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.013 · Cited by 1,162
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Disordered lipid metabolism and the pathogenesis of insulin resistance.
Savage, D. B., Petersen, K. F., & Shulman, G. I. (2007) · Physiological Reviews · doi:10.1152/physrev.00024.2006 · Cited by 1,107 · cited 1×
“Decreasing hepatic fatty acid content has well-documented effects on liver insulin sensitivity in a variety of models and indirectly improves the responsiveness of hepatic glucose production, via either glycogenolysis or gluconeogenesis (38, 39).”
BackgroundHandschin, C., & Spiegelman, B. M. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0037 · Cited by 1,090
Leone, T. C., Lehman, J. J., Finck, B. N., Schaeffer, P. J., Wende, A. R., Boudina, S., Courtois, M., Wozniak, D. F., Sambandam, N., Bernal-Mizrachi, C., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030101 · Cited by 951
Self-citationLeone, T. C., Weinheimer, C. J., & Kelly, D. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7473 · Cited by 943
Kurosu, H., Choi, M., Ogawa, Y., Dickson, A. S., Goetz, R., Eliseenkova, A. V., Mohammadi, M., Rosenblatt, K. P., Kliewer, S. A., & Kuro-o, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704165200 · Cited by 748
Self-citationThe metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21
Kharitonenkov, A., Wroblewski, V. J., Koester, A., Chen, Y.-F., Clutinger, C. K., Tigno, X. T., Hansen, B. C., Shanafelt, A. B., & Etgen, G. J. (2007) · Endocrinology · doi:10.1210/en.2006-1168 · Cited by 738 · cited 2×
“Pharmacologic administration of FGF21 to insulin-resistant rodents and monkeys improves glucose tolerance and reduces plasma insulin and triglyceride concentrations (15, 17).”
BackgroundβKlotho is required for metabolic activity of fibroblast growth factor 21
Ogawa, Y., Kurosu, H., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Goetz, R., Eliseenkova, A. V., Mohammadi, M., & Kuro-o, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701600104 · Cited by 617
Self-citationFu, L., John, L. M., Adams, S. H., Yu, X. X., Tomlinson, E., Renz, M., Williams, P. M., Soriano, R., Corpuz, R., Moffat, B., et al. (2004) · Endocrinology · doi:10.1210/en.2003-1671 · Cited by 579 · cited 1×
“FGF21 functions as a potent insulin sensitizer in various animal models of insulin resistance and diabetes (15, 17, 36, 37).”
BackgroundTomlinson, E., Fu, L., John, L., Hultgren, B., Huang, X., Renz, M., Stephan, J. P., Tsai, S. P., Powell-Braxton, L., French, D., et al. (2002) · Endocrinology · doi:10.1210/endo.143.5.8850 · Cited by 576 · cited 1×
“FGF21 functions as a potent insulin sensitizer in various animal models of insulin resistance and diabetes (15, 17, 36, 37).”
BackgroundRhee, J., Inoue, Y., Yoon, J. C., Puigserver, P., Fan, M., Gonzalez, F. J., & Spiegelman, B. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730870100 · Cited by 567
PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3
Koo, S.-H., Satoh, H., Herzig, S., Lee, C.-H., Hedrick, S., Kulkarni, R., Evans, R. M., Olefsky, J., & Montminy, M. (2004) · Nature Medicine · doi:10.1038/nm1044 · Cited by 550
Goetz, R., Beenken, A., Ibrahimi, O. A., Kalinina, J., Olsen, S. K., Eliseenkova, A. V., Xu, C., Neubert, T. A., Zhang, F., Linhardt, R. J., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02249-06 · Cited by 544 · cited 1×
“FGF21 is an unusual FGF family member in that it lacks the conventional heparinbinding domain (8) and thus can diffuse away from its tissue of origin and function as a hormone.”
BackgroundSelf-citationGälman, C., Lundåsen, T., Kharitonenkov, A., Bina, H. A., Eriksson, M., Hafström, I., Dahlin, M., Åmark, P., Angelin, B., & Rudling, M. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.014 · Cited by 512 · cited 1×
“First, circulating FGF21 concentrations are induced in rodents and humans only after prolonged fasting (5, 6, 33).”
BackgroundQuantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways
Bookout, A. L., & Mangelsdorf, D. J. (2003) · Nuclear Receptor Signaling · doi:10.1621/nrs.01012 · Cited by 449
Self-citationInhibition of Growth Hormone Signaling by the Fasting-Induced Hormone FGF21
Inagaki, T., Lin, V. Y., Goetz, R., Mohammadi, M., Mangelsdorf, D. J., & Kliewer, S. A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.05.006 · Cited by 409 · cited 1×
“FGF21 has diverse metabolic actions that include stimulating hepatic fatty acid oxidation and ketogenesis (5, 6, 15) and blocking the growth hormone signaling pathway (16).”
BackgroundSelf-citationPPARα is a key regulator of hepatic FGF21
Lundåsen, T., Hunt, M. C., Nilsson, L.-M., Sanyal, S., Angelin, B., Alexson, S. E. H., & Rudling, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.068 · Cited by 383
Nutritional Regulation of Hepatic Heme Biosynthesis and Porphyria through PGC-1α
Handschin, C., Lin, J., Rhee, J., Peyer, A.-K., Chin, S., Wu, P.-H., Meyer, U. A., & Spiegelman, B. M. (2005) · Cell · doi:10.1016/j.cell.2005.06.040 · Cited by 383
Suzuki, M., Uehara, Y., Motomura-Matsuzaka, K., Oki, J., Koyama, Y., Kimura, M., Asada, M., Komi-Kuramochi, A., Oka, S., & Toru, T. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0313 · Cited by 345
Ye, J.-M., Doyle, P. J., Iglesias, M. A., Watson, D. G., Cooney, G. J., & Kraegen, E. W. (2001) · Diabetes · doi:10.2337/diabetes.50.2.411 · Cited by 343 · cited 1×
“In this respect, the effects of FGF21 are analogous to those of PPAR agonists, which improve hepatic insulin action and overall glycemic control in diabetic rodents despite increasing hepatic gluconeogenesis (40, 41).”
BackgroundGlucagon levels and metabolic effects in fasting man
Marliss, E. B., Aoki, T. T., Unger, R. H., Soeldner, J. S., & Cahill, G. F. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106445 · Cited by 339
FGF‐21/FGF‐21 receptor interaction and activation is determined by βKlotho
Kharitonenkov, A., Dunbar, J. D., Bina, H. A., Bright, S., Moyers, J. S., Zhang, C., Ding, L., Micanovic, R., Mehrbod, S. F., Knierman, M. D., et al. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21357 · Cited by 328
Liver-specific Activities of FGF19 Require Klotho beta
Lin, B. C., Wang, M., Blackmore, C., & Desnoyers, L. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704244200 · Cited by 283
Burgess, S. C., He, T., Yan, Z., Lindner, J., Sherry, A. D., Malloy, C. R., Browning, J. D., & Magnuson, M. A. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.03.004 · Cited by 276 · cited 1×
“1 mM [U-(13)C3]propionate as described previously (3, 4, 44, 45).”
MethodSelf-citationThe Glucagon Receptor Is Required for the Adaptive Metabolic Response to Fasting
Longuet, C., Sinclair, E. M., Maida, A., Baggio, L. L., Maziarz, M., Charron, M. J., & Drucker, D. J. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.008 · Cited by 272 · cited 1×
“Because glucagon and its downstream effector, cAMP, induce PGC-1 and gluconeogenic gene expression during the early stages of the fasting response (24, 35), we propose that FGF21 maintains the expression of these genes during prolonged fasting and starvation.”
BackgroundMouse models of insulin resistance
Hribal, M. L., Oriente, F., & Accili, D. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00561.2001 · Cited by 252 · cited 1×
“Decreasing hepatic fatty acid content has well-documented effects on liver insulin sensitivity in a variety of models and indirectly improves the responsiveness of hepatic glucose production, via either glycogenolysis or gluconeogenesis (38, 39).”
BackgroundMouse Models of Insulin Resistance
NANDI, A., KITAMURA, Y., KAHN, C. R., & ACCILI, D. (2004) · Physiological Reviews · doi:10.1152/physrev.00032.2003 · Cited by 231
The Regulation of Ketogenesis from Octanoic Acid
McGarry, J. D., & Foster, D. W. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62443-3 · Cited by 183
Co-receptor Requirements for Fibroblast Growth Factor-19 Signaling
Wu, X., Ge, H., Gupte, J., Weiszmann, J., Shimamoto, G., Stevens, J., Hawkins, N., Lemon, B., Shen, W., Xu, J., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700130200 · Cited by 140
The direct and indirect effects of insulin on hepatic glucose production in vivo
Cherrington, A. D., Edgerton, D. S., & Sindelar, D. K. (1998) · Diabetologia · doi:10.1007/s001250051021 · Cited by 137 · cited 1×
“These data are consistent with an increased reliance on gluconeogenesis and an autoregulatory sparing of glycogen (29).”
BackgroundWright, T. J., Ladher, R. K., McWhirter, J. R., Murre, C., Schoenwolf, G. C., & Mansour, S. L. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.02.003 · Cited by 131 · cited 1×
“FGF21-TG, PGC-1 -KO, and Meox-cre mice were described previously (6, 28, 42, 43).”
Hakimi, P., Johnson, M. T., Yang, J., Lepage, D. F., Conlon, R. A., Kalhan, S. C., Reshef, L., Tilghman, S. M., & Hanson, R. W. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-33 · Cited by 121
Burgess, S. C., Leone, T. C., Wende, A. R., Croce, M. A., Chen, Z., Sherry, A. D., Malloy, C. R., & Finck, B. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600050200 · Cited by 111 · cited 2×
“NMR isotopomer analyses show that PGC-1 -KO liver has reductions in fatty acid oxidation, ketogenesis, TCA flux, and gluconeogenesis that mirror those in the FGF21-KO liver (4).”
BackgroundMethodSelf-citationKinetics of glucagon in man: effects of starvation.
Fisher, M., Sherwin, R. S., Hendler, R., & Felig, P. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.5.1735 · Cited by 78
Effect of murine strain on metabolic pathways of glucose production after brief or prolonged fasting
Burgess, S. C., Jeffrey, F. M. H., Storey, C., Milde, A., Hausler, N., Merritt, M. E., Mulder, H., Holm, C., Sherry, A. D., & Malloy, C. R. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00601.2004 · Cited by 71 · cited 1×
“1 mM [U-(13)C3]propionate as described previously (3, 4, 44, 45).”
MethodSelf-citationSatapati, S., He, T., Inagaki, T., Potthoff, M., Merritt, M. E., Esser, V., Mangelsdorf, D. J., Kliewer, S. A., Browning, J. D., & Burgess, S. C. (2008) · Diabetes · doi:10.2337/db08-0226 · Cited by 52 · cited 1×
“In this respect, the effects of FGF21 are analogous to those of PPAR agonists, which improve hepatic insulin action and overall glycemic control in diabetic rodents despite increasing hepatic gluconeogenesis (40, 41).”
BackgroundSelf-citationBurgess, S. C., Nuss, M. E., Chandramouli, V., Hardin, D. S., Rice, M., Landau, B. R., Malloy, C. R., & Sherry, A. D. (2003) · Analytical Biochemistry · doi:10.1016/s0003-2697(03)00158-1 · Cited by 41 · cited 1×
“1 mM [U-(13)C3]propionate as described previously (3, 4, 44, 45).”
MethodSelf-citation(2000) · doi:10.1002/(sici)1526-968x(200002)26:2<113::aid-gene3>3.0.co;2-2 · cited 1×
“FGF21-TG, PGC-1 -KO, and Meox-cre mice were described previously (6, 28, 42, 43).”
Cited by
Energy Metabolism in the Liver
Rui, L. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130024 · Cited by 1,953
“2B), TCA flux, and ketogenesis (212).”
FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis
Fisher, F. M., Kleiner, S., Douris, N., Fox, E. C., Mepani, R. J., Verdeguer, F., Wu, J., Kharitonenkov, A., Flier, J. S., Maratos-Flier, E., et al. (2012) · Genes & Development · doi:10.1101/gad.177857.111 · Cited by 1,478
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
Understanding the Physiology of FGF21
Fisher, F. M., & Maratos-Flier, E. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105339 · Cited by 912
FGF/FGFR signaling in health and disease
Xie, Y., Su, N., Yang, J., Tan, Q., Huang, S., Jin, M., Ni, Z., Zhang, B., Zhang, D., Luo, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00222-7 · Cited by 904
“FGF21 knockout mice fail to induce PGC-1α expression and have impaired gluconeogenesis and ketogenesis in response to a prolonged fast.(559) However, the mechanisms for the regulation of FGF21 on liver metabolism need to be further explored.”
BackgroundInfluential
Metadata
- Authors
- Potthoff, M. J., Inagaki, T., Satapati, S., Ding, X., He, T., Goetz, R., Mohammadi, M., Finck, B. N., Mangelsdorf, D. J., Kliewer, S. A., & Burgess, S. C.
- Affiliations
- Howard Hughes Medical Institute (US)
- The University of Texas Southwestern Medical Center (US)
- New York University (US)
- Washington University in St. Louis (US)
- Department of Pharmacology,
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-06-30
- Volume
- 106
- Issue
- 26
- Pages
- 10853-10858
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2705613
- OpenAlex
- W1993235686
- Cited by
- 704
- References
- 48
- Citations by year
- 2026: 25 · 2025: 35 · 2024: 41 · 2023: 38 · 2022: 49 · 2021: 62 · 2020: 40 · 2019: 49 · 2018: 51 · 2017: 42 · 2016: 60 · 2015: 48 · 2014: 46 · 2013: 29 · 2012: 42
- FWCI
- 11.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute of General Medical Sciences (RL1GM084436)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-067158, U19 DK-62434, DK078184, DK-076269, U19DK062434, R01DK067158, R01DK078184)
- National Institute of Dental and Craniofacial Research (DE13686, R01DE013686)
- National Center for Research Resources (P41RR002584, P20RR20691, RR‐02584, P20RR020691)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- FGF21, PGC-1α, fasting, starvation, hepatic gluconeogenesis, ketogenesis, glycogenolysis, fatty acid oxidation, TCA cycle, energy homeostasis, liver, energy mobilization
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Adaptation, Physiological, Animals, Blood Glucose, Body Weight, Fasting, Fatty Acids, Female, Fibroblast Growth Factors, Gene Expression Regulation, Gluconeogenesis, Insulin, Liver, Male, Mice, Inbred C57BL, Mice, Transgenic, Oxidation-Reduction, Starvation, Transcription Factors, Triglycerides, Blotting, Western, Trans-Activators, Mice, Knockout, Reverse Transcriptase Polymerase Chain Reaction, Carbohydrate Metabolism, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.